...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Validity of Reported Varicella History as a Marker for Varicella Zoster Virus Immunity Among Unvaccinated Children, Adolescents, and Young Adults in the Post–Vaccine Licensure Era
【24h】

Validity of Reported Varicella History as a Marker for Varicella Zoster Virus Immunity Among Unvaccinated Children, Adolescents, and Young Adults in the Post–Vaccine Licensure Era

机译:疫苗接种后时代未接种疫苗的儿童,青少年和年轻成年人中水痘病史作为水痘带状疱疹病毒免疫力标记的有效性

获取原文
           

摘要

OBJECTIVES. We assessed the validity of reported varicella history as a marker for varicella zoster virus immunity among unvaccinated persons 1 to 29 years of age, and we examined varicella disease characteristics associated with varicella zoster virus immunity among those reporting positive histories.METHODS. We conducted a cross-sectional study at 7 community-based sites in Philadelphia, Pennsylvania, between June 2004 and May 2006 and recruited 1476 participants 1 to 29 years of age who had not been vaccinated against varicella. Sensitivity, specificity, and positive predictive value were determined by comparing self-reported or parent-reported varicella histories from a standardized study interview with varicella zoster virus immunoglobulin G serological results for each participant. We performed multivariate logistic regression analyses to determine which disease characteristics best predicted seropositivity.RESULTS. The sensitivity of reported varicella history was highest (81%–89%) among participants ≥10 years of age, whereas specificity was highest among participants 1 to 4 years of age (99%) and ≥20 years (88%). Reported varicella history was highly predictive of seropositivity (95%) only among participants ≥15 years of age. For participants 10 to 14 years of age, parental reports of a generalized itchy rash with 1 of the following were highly predictive of seropositivity: varicella transmission to another household member or being raised in a household with no other children. Among participants ≤9 years of age, no combination of disease characteristics was both highly predictive of seropositivity and common.CONCLUSIONS. The validity of reported varicella history varies according to age, and a reported history is no longer highly predictive of seropositivity among cohorts born since 1994 (participants ≤9 years of age). Universal varicella vaccination, regardless of history, for these children should be considered, as should simplified criteria for varicella zoster virus immunity among unvaccinated persons born before 1994.
机译:目标我们评估了报告的水痘病史作为1至29岁未接种疫苗的人中水痘带状疱疹病毒免疫性标记的有效性,并且我们在报告阳性历史的人群中检查了与水痘带状疱疹病毒免疫性相关的水痘疾病特征。我们于2004年6月至2006年5月在宾夕法尼亚州费城的7个社区站点进行了横断面研究,并招募了1476名年龄在1至29岁之间的未接种过水痘疫苗的参与者。通过比较来自标准研究访谈的自我报告或父母报告的水痘历史与水痘带状疱疹病毒免疫球蛋白G血清学结果,来确定敏感性,特异性和阳性预测值。我们进行了多变量logistic回归分析,以确定哪些疾病特征最能预测血清阳性。在≥10岁的参与者中,报告的水痘病史的敏感性最高(81%–89%),而在1至4岁的参与者(99%)和≥20岁(88%)中的特异性最高。仅在≥15岁的参与者中,报告的水痘病史可高度预测血清阳性(> 95%)。对于10至14岁的参与者,父母报告有以下一种情况的全身瘙痒性皮疹可高度预测血清阳性:将水痘传播给另一位家庭成员或在没有其他孩子的家庭中长大。在≤9岁的参与者中,没有疾病特征的组合既可以高度预测血清阳性,也可以普遍预测。报告的水痘病史的有效性因年龄而异,并且报道的病史不再高度预测1994年以来出生的队列(参与者≤9岁)的血清阳性。应当考虑对这些儿童进行普遍的水痘疫苗接种,无论其病史如何,也应考虑对1994年前出生的未接种疫苗的人进行水痘带状疱疹病毒免疫的简化标准。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号